Search Results - "Fernandez Abad, Maria"

Refine Results
  1. 1

    OMIP‐087: Thirty‐two parameter mass cytometry panel to assess human CD4 and CD8 T cell activation, memory subsets, and helper subsets by Sponaugle, Alexis, AbadFernandez, Maria, Goonetilleke, Nilu

    Published in Cytometry. Part A (01-03-2023)
    “…We developed a highly reproducible 32‐marker mass cytometry panel able to measure all canonical immune lineages and perform detailed characterization of both…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Reliable Estimation of CD8 T Cell Inhibition of In Vitro HIV-1 Replication by Xu, Yinyan, Weideman, Ann Marie, Abad-Fernandez, Maria, Mollan, Katie R, Kallon, Sallay, Samir, Shahryar, Warren, Joanna A, Clutton, Genevieve, Roan, Nadia R, Adimora, Adaora A, Archin, Nancie, Kuruc, JoAnn, Gay, Cindy, Hudgens, Michael G, Goonetilleke, Nilu

    Published in Frontiers in immunology (30-06-2021)
    “…The HIV-1 viral inhibition assay (VIA) measures CD8 T cell-mediated inhibition of HIV replication in CD4 T cells and is increasingly used for clinical testing…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Molecular effects of lapatinib in patients with HER2 positive ductal carcinoma in situ by Estévez, Laura G, Suarez-Gauthier, Ana, García, Elena, Miró, Cristina, Calvo, Isabel, Fernández-Abad, María, Herrero, Mercedes, Marcos, Manuel, Márquez, Cristina, Lopez Ríos, Fernando, Perea, Sofía, Hidalgo, Manuel

    Published in Breast cancer research : BCR (04-09-2014)
    “…Human epidermal growth factor receptor 2 (HER2) amplification is frequent in ductal carcinoma in situ (DCIS) of the breast and is associated with poorly…”
    Get full text
    Journal Article
  12. 12

    CD8 T Cell Virus Inhibition Assay Protocol by Xu, Yinyan, Weideman, Ann Marie, Abad-Fernandez, Maria, Mollan, Katie R, Kallon, Sallay, Samir, Shahryar, Warren, Joanna A, Clutton, Genevieve, Roan, Nadia, Adimora, Adaora A, Archin, Nancie, Kuruc, JoAnn, Gay, Cindy, Hudgens, Michael G, Goonetilleke, Nilu

    Published in Bio-protocol (20-03-2022)
    “…The human immunodeficiency virus (HIV)-1 viral inhibition assay (VIA) measures CD8 T cell-mediated inhibition of HIV replication in CD4 T cells and is…”
    Get full text
    Journal Article
  13. 13

    Concluding Remarks for Special Issue HTLV-HIV Co-Infections by Vallejo, Alejandro, Abad-Fernández, María

    Published in Viruses (01-04-2023)
    “…During the early 1980s, the first 3 human retroviruses were identified: human T-lymphotropic virus 1 and 2 (HTLV-1 and HTLV-2) and human immunodeficiency virus…”
    Get full text
    Journal Article
  14. 14

    Human cytomegalovirus-vectored vaccines against HIV by Abad-Fernandez, Maria, Goonetilleke, Nilu

    Published in Current opinion in HIV & AIDS (01-03-2019)
    “…PURPOSE OF REVIEWCMV-vectored vaccines expressing SIV antigens have mediated unprecedented levels of virus control following SIV challenge in rhesus macaques…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo by Garrido, Carolina, Abad-Fernandez, Maria, Tuyishime, Marina, Pollara, Justin J, Ferrari, Guido, Soriano-Sarabia, Natalia, Margolis, David M

    Published in Journal of virology (15-06-2018)
    “…Current efforts toward human immunodeficiency virus (HIV) eradication include approaches to augment immune recognition and elimination of persistently infected…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Conserved-region MVA vaccines can shift HIV T cell immunodominance in PWH on ART - the M&M Study by Xu, Yinyan, Samir, shahryat, Weideman, Ann Marie K., Kallon, Sallay, Conrad, Shayla, Shaw, Fiona, Warren, Joanna, Fernandez, Maria Abad, Fox, Lawrence, Margolis, David M., Hudgens, Michael G., Hanke, Tomas, Kuruc, JoAnn, Gay, Cindy, Goonetilleke, Nilu

    Published in The Journal of immunology (1950) (01-05-2022)
    “…CD8+ T cell immunity is essential to the control of HIV viremia. We examined the safety and immunogenicity of MVA-vectored vaccines expressing highly conserved…”
    Get full text
    Journal Article